201 related articles for article (PubMed ID: 26453210)
21. Alpha-Synuclein Proximity Ligation Assay (AS-PLA) in Brain Sections to Probe for Alpha-Synuclein Oligomers.
Roberts RF; Bengoa-Vergniory N; Alegre-Abarrategui J
Methods Mol Biol; 2019; 1948():69-76. PubMed ID: 30771171
[TBL] [Abstract][Full Text] [Related]
22. DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein.
Atieh TB; Roth J; Yang X; Hoop CL; Baum J
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680099
[TBL] [Abstract][Full Text] [Related]
23. Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease.
Deas E; Cremades N; Angelova PR; Ludtmann MH; Yao Z; Chen S; Horrocks MH; Banushi B; Little D; Devine MJ; Gissen P; Klenerman D; Dobson CM; Wood NW; Gandhi S; Abramov AY
Antioxid Redox Signal; 2016 Mar; 24(7):376-91. PubMed ID: 26564470
[TBL] [Abstract][Full Text] [Related]
24. Oleuropein derivatives from olive fruit extracts reduce α-synuclein fibrillation and oligomer toxicity.
Mohammad-Beigi H; Aliakbari F; Sahin C; Lomax C; Tawfike A; Schafer NP; Amiri-Nowdijeh A; Eskandari H; Møller IM; Hosseini-Mazinani M; Christiansen G; Ward JL; Morshedi D; Otzen DE
J Biol Chem; 2019 Mar; 294(11):4215-4232. PubMed ID: 30655291
[TBL] [Abstract][Full Text] [Related]
25. The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity.
Xu CK; Castellana-Cruz M; Chen SW; Du Z; Meisl G; Levin A; Mannini B; Itzhaki LS; Knowles TPJ; Dobson CM; Cremades N; Kumita JR
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209093
[TBL] [Abstract][Full Text] [Related]
26. Ca2+ is a key factor in α-synuclein-induced neurotoxicity.
Angelova PR; Ludtmann MH; Horrocks MH; Negoda A; Cremades N; Klenerman D; Dobson CM; Wood NW; Pavlov EV; Gandhi S; Abramov AY
J Cell Sci; 2016 May; 129(9):1792-801. PubMed ID: 26989132
[TBL] [Abstract][Full Text] [Related]
27. Generation and Characterization of Stable α-Synuclein Oligomers.
Almandoz-Gil L; Ingelsson M; Bergström J
Methods Mol Biol; 2018; 1779():61-71. PubMed ID: 29886527
[TBL] [Abstract][Full Text] [Related]
28. Expression and Purification of Untagged α-Synuclein.
Powers AE; Patel DS
Methods Mol Biol; 2019; 1948():261-269. PubMed ID: 30771184
[TBL] [Abstract][Full Text] [Related]
29. X-ray Crystallographic Structure of Oligomers Formed by a Toxic β-Hairpin Derived from α-Synuclein: Trimers and Higher-Order Oligomers.
Salveson PJ; Spencer RK; Nowick JS
J Am Chem Soc; 2016 Apr; 138(13):4458-67. PubMed ID: 26926877
[TBL] [Abstract][Full Text] [Related]
30. Preparation of α-Synuclein Amyloid Assemblies for Toxicity Experiments.
Chen SW; Cremades N
Methods Mol Biol; 2018; 1779():45-60. PubMed ID: 29886526
[TBL] [Abstract][Full Text] [Related]
31. α-Synuclein is a Novel Microtubule Dynamase.
Cartelli D; Aliverti A; Barbiroli A; Santambrogio C; Ragg EM; Casagrande FV; Cantele F; Beltramone S; Marangon J; De Gregorio C; Pandini V; Emanuele M; Chieregatti E; Pieraccini S; Holmqvist S; Bubacco L; Roybon L; Pezzoli G; Grandori R; Arnal I; Cappelletti G
Sci Rep; 2016 Sep; 6():33289. PubMed ID: 27628239
[TBL] [Abstract][Full Text] [Related]
32. Measuring Mitochondrial Dysfunction Caused by Soluble α-Synuclein Oligomers.
Luth ES; Stavrovskaya IG
Methods Mol Biol; 2019; 1948():183-198. PubMed ID: 30771178
[TBL] [Abstract][Full Text] [Related]
33. Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds.
Caruana M; Högen T; Levin J; Hillmer A; Giese A; Vassallo N
FEBS Lett; 2011 Apr; 585(8):1113-20. PubMed ID: 21443877
[TBL] [Abstract][Full Text] [Related]
34. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy.
Apetri MM; Maiti NC; Zagorski MG; Carey PR; Anderson VE
J Mol Biol; 2006 Jan; 355(1):63-71. PubMed ID: 16303137
[TBL] [Abstract][Full Text] [Related]
35. Defining the native state of α-synuclein.
Selkoe D; Dettmer U; Luth E; Kim N; Newman A; Bartels T
Neurodegener Dis; 2014; 13(2-3):114-7. PubMed ID: 24192542
[TBL] [Abstract][Full Text] [Related]
36. Strong interactions with polyethylenimine-coated human serum albumin nanoparticles (PEI-HSA NPs) alter α-synuclein conformation and aggregation kinetics.
Mohammad-Beigi H; Shojaosadati SA; Marvian AT; Pedersen JN; Klausen LH; Christiansen G; Pedersen JS; Dong M; Morshedi D; Otzen DE
Nanoscale; 2015 Dec; 7(46):19627-40. PubMed ID: 26549058
[TBL] [Abstract][Full Text] [Related]
37. Structural Characteristics of α-Synuclein Oligomers.
Cremades N; Chen SW; Dobson CM
Int Rev Cell Mol Biol; 2017; 329():79-143. PubMed ID: 28109332
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence correlation spectroscopy to determine the diffusion coefficient of α-synuclein and follow early oligomer formation.
Nath S; Deng M; Engelborghs Y
Methods Mol Biol; 2012; 895():499-506. PubMed ID: 22760336
[TBL] [Abstract][Full Text] [Related]
39. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
[TBL] [Abstract][Full Text] [Related]
40. Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
Stefanovic AN; Lindhoud S; Semerdzhiev SA; Claessens MM; Subramaniam V
Biochemistry; 2015 May; 54(20):3142-50. PubMed ID: 25909158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
